NCT02772146 is a NA clinical trial of CLS UF in Heart Failure, sponsored by Triomed AB.

Who is sponsoring NCT02772146?

NCT02772146 is sponsored by Triomed AB.

What drugs are being tested in NCT02772146?

Interventions in NCT02772146: CLS UF.

What condition does NCT02772146 study?

NCT02772146 studies Heart Failure, Cardio-Renal Syndrome.

Is NCT02772146 still recruiting?

NCT02772146 is currently terminated. Last updated 14 March 2017.

Last reviewed 2017-03-14 · How we verify

NCT02772146

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Clinical Study of the Safety and Efficacy of a Wearable Device (CLS UF) That Delivers Continuous Administration of Glucose to Recirculated Peritoneal Dialysis Fluid for the Purpose of Ultrafiltration in Patients With Congestive Heart Failure

Terminated NA Last updated 14 March 2017

What this trial tests

NA trial testing CLS UF in Heart Failure in 2 participants. Terminated before completion.

Timeline

11 May 2016

Primary endpoint
23 January 2017

23 January 2017

Quick facts

Lead sponsor	Triomed AB
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	2
Start date	11 May 2016
Primary completion	23 January 2017
Estimated completion	23 January 2017
Sites	1 location across Germany

Drugs / interventions tested

CLS UF

Conditions studied

Heart Failure — all drugs for Heart Failure →
Cardio-Renal Syndrome — all drugs for Cardio-Renal Syndrome →

Sponsor

Triomed AB — full company profile →

Who can join

Adults 18 to 80, any sex, with Heart Failure or Cardio-Renal Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A single-center, prospective, non-randomized, clinical and first-in-human study. Each patient will be studied during a single treatment session of ten hours. The device will be connected to an existing, standard PD catheter that the patient will be using routinely prior to the study (i.e. a peritoneal dialysis catheter will not be specifically inserted for the study). The patient will be hospitalized for observation during the test day and during the night following the study session. Ultrafiltration volume, dialysate glucose concentrations, blood glucose concentrations as well the patient's acceptability and tolerance of the wearable device will be evaluated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Heart Failure

Currently open trials in the same condition.

NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF) · NA · recruiting
NCT07496372 — Efficacy and Safety of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Injection (HiCM-188) in Advanced Heart · Phase 3 · recruiting
NCT07527156 — Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure · Phase 4 · recruiting
NCT07263035 — Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure · Phase 4 · recruiting
NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting

Other Triomed AB trials

Trials by the same sponsor.

NCT05874804 — Carry Life@ UF System Clinical Study · NA · completed
NCT03724682 — A Performance Analysis of the Peritoneal Ultrafiltration (PUF) Achieved With the Carry Life® UF · NA · completed
NCT03190018 — A Feasibility Study of Peritoneal Dialysis With CLS PD, Which Removes Toxins and Maintains a Stable Ultrafiltration by C · NA · completed
NCT03128073 — A Feasibility Study of Peritoneal Ultrafiltration With a Wearable Device, CLS UF, That Adds a Glucose-salt Solution to t · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02772146 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Triomed AB
Last refreshed: 14 March 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02772146.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing